BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36284346)

  • 1. Efficacy and safety of carbon ion radiotherapy for bone sarcomas: a systematic review and meta-analysis.
    Dong M; Liu R; Zhang Q; Luo H; Wang D; Wang Y; Chen J; Ou Y; Wang X
    Radiat Oncol; 2022 Oct; 17(1):172. PubMed ID: 36284346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particle Therapy Using Protons or Carbon Ions for Unresectable or Incompletely Resected Bone and Soft Tissue Sarcomas of the Pelvis.
    Demizu Y; Jin D; Sulaiman NS; Nagano F; Terashima K; Tokumaru S; Akagi T; Fujii O; Daimon T; Sasaki R; Fuwa N; Okimoto T
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):367-374. PubMed ID: 28463156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of carbon ion radiotherapy for chordomas: a systematic review and meta-analysis.
    Dong M; Liu R; Zhang Q; Wang D; Luo H; Wang Y; Chen J; Ou Y; Wang X
    Radiat Oncol; 2023 Sep; 18(1):152. PubMed ID: 37705083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local surgery feasibility and safety after carbon ion radiotherapy for primary bone sarcomas.
    Sabe H; Outani H; Imura Y; Takami H; Nakai T; Takenaka S; Kakunaga S; Tamiya H; Wakamatsu T; Nakai S; Demizu Y; Imai R; Okada S
    J Orthop Sci; 2024 May; 29(3):903-907. PubMed ID: 37045686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Efficacy of Carbon Ion Radiotherapy for Unresectable Chondrosarcomas.
    Imai R; Kamada T; Araki N;
    Anticancer Res; 2017 Dec; 37(12):6959-6964. PubMed ID: 29187480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon ion radiotherapy for skull base chordomas and chondrosarcomas: a systematic review and meta-analysis of local control, survival, and toxicity outcomes.
    Lu VM; O'Connor KP; Mahajan A; Carlson ML; Van Gompel JJ
    J Neurooncol; 2020 May; 147(3):503-513. PubMed ID: 32206977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
    Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
    Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of proton beam therapy for rhabdomyosarcoma: a systematic review and meta-analysis.
    Dong M; Wu J; Wu R; Wang D; Liu R; Luo H; Wang Y; Chen J; Ou Y; Zhang Q; Wang X
    Radiat Oncol; 2023 Feb; 18(1):31. PubMed ID: 36805784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome and Toxicity of Carbon Ion Radiotherapy for Axial Bone and Soft Tissue Sarcomas.
    Cuccia F; Fiore MR; Barcellini A; Iannalfi A; Vischioni B; Ronchi S; Bonora M; Riva G; Vai A; Facoetti A; Preda L; Valvo F; Vitolo V
    Anticancer Res; 2020 May; 40(5):2853-2859. PubMed ID: 32366434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine.
    Guan X; Gao J; Hu J; Hu W; Yang J; Qiu X; Hu C; Kong L; Lu JJ
    Radiat Oncol; 2019 Nov; 14(1):206. PubMed ID: 31752953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of carbon ion radiotherapy for primary spinal sarcoma.
    Matsumoto K; Imai R; Kamada T; Maruyama K; Tsuji H; Tsujii H; Shioyama Y; Honda H; Isu K;
    Cancer; 2013 Oct; 119(19):3496-503. PubMed ID: 23939877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-Modulated Proton and Carbon-Ion Radiation Therapy in the Management of Head and Neck Sarcomas.
    Yang J; Gao J; Qiu X; Hu J; Hu W; Wu X; Zhang C; Ji T; Kong L; Lu JJ
    Cancer Med; 2019 Aug; 8(10):4574-4586. PubMed ID: 31231939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy in bone sarcoma: the quest for better treatment option.
    Locquet MA; Brahmi M; Blay JY; Dutour A
    BMC Cancer; 2023 Aug; 23(1):742. PubMed ID: 37563551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon-ion Radiotherapy for Inoperable Head and Neck Bone and Soft-tissue Sarcoma: Prospective Observational Study.
    Musha A; Kubo N; Kawamura H; Okano N; Sato H; Okada K; Osu N; Yumisaki H; Adachi A; Takayasu Y; Shino M; Nikkuni O; Ida S; Shirai K; Saitoh JI; Yokoo S; Chikamatsu K; Ohno T
    Anticancer Res; 2022 Mar; 42(3):1439-1446. PubMed ID: 35220237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone sarcomas.
    AlvegÄrd T
    Acta Oncol; 1996; 35 Suppl 7():123-4. PubMed ID: 9154104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A risk factor analysis for local recurrence of bone and soft tissue sarcoma treated with carbon ion radiotherapy: A retrospective cohort study at a single institution.
    Kohama I; Yanagawa T; Okamoto M; Ohno T; Chikuda H
    Asia Pac J Clin Oncol; 2022 Aug; 18(4):434-440. PubMed ID: 34811886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of charged-particle therapy for chordomas and sarcomas of the mobile spine and sacrum.
    Pennington Z; Ehresman J; Elsamadicy AA; Shin JH; Goodwin CR; Schwab JH; Sciubba DM
    Neurosurg Focus; 2021 May; 50(5):E17. PubMed ID: 33932924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcoma in Older Patients.
    Kinoshita H; Yonemoto T; Yamada S; Imai R
    Anticancer Res; 2024 Apr; 44(4):1773-1780. PubMed ID: 38537982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas.
    Kamada T; Tsujii H; Tsuji H; Yanagi T; Mizoe JE; Miyamoto T; Kato H; Yamada S; Morita S; Yoshikawa K; Kandatsu S; Tateishi A;
    J Clin Oncol; 2002 Nov; 20(22):4466-71. PubMed ID: 12431970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and Safety of Carbon Ion Radiotherapy in Solid Tumors: A Systematic Review and Meta-Analysis.
    Yun JE; Kim S; Park KY; Lee W
    Yonsei Med J; 2024 Jun; 65(6):332-340. PubMed ID: 38804027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.